Eascra Biotech develops DNA nanostructures to create stable nanomaterials for biomedical applications.
Eascra Biotech has raised $100K in total funding. The most recent round was Grant. The last funding was announced in May 2025.
Eascra Biotech's investors include National Science Foundation, MassVentures, NASA.
Eascra Biotech is headquartered in Boston, United States.
Eascra Biotech develops DNA nanostructures to create stable nanomaterials for biomedical applications.
Eascra Biotech is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Eascra Biotech — Funding & Investors." VCBacked, May 16, 2025, https://www.vcbacked.co/company/eascra-biotech. Accessed October 13, 2026.
VCBacked. (2025). Eascra Biotech — Funding & Investors. Retrieved October 13, 2026, from https://www.vcbacked.co/company/eascra-biotech
{{cite web |title=Eascra Biotech — Funding & Investors |url=https://www.vcbacked.co/company/eascra-biotech |website=VCBacked |access-date=October 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated